Related Experiment Video

Updated: Aug 16, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

Emma K Baker1, Ricky W Johnstone, John R Zalcberg

  • 1Epigenetics in Human Health and Disease Laboratory, The Alfred Medical Research and Education Precinct, Baker Medical Research Institute, Commercial Road, Prahran, Victoria 3181, Australia.

Oncogene
|August 11, 2005
PubMed

Insights

Chemotherapeutic drugs trigger epigenetic changes at the MDR1 gene, increasing P-glycoprotein (Pgp) expression and contributing to multidrug resistance (MDR) in cancer cells. These epigenetic modifications, including histone changes, are key to understanding and potentially overcoming treatment resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Chemotherapy efficacy is limited by multidrug resistance (MDR).
  • Overexpression of P-glycoprotein (Pgp) via the MDR1 gene is a primary mechanism of MDR.
  • The precise mechanisms by which cells achieve high Pgp levels remain unclear.

Purpose of the Study:

  • To investigate the epigenetic mechanisms underlying MDR1 gene upregulation induced by chemotherapeutic drugs.
  • To elucidate the role of histone modifications and DNA methylation in MDR development.

Main Methods:

  • Analysis of epigenetic modifications at the MDR1 locus in response to chemotherapy.
  • Assessment of MDR1 gene expression and Pgp levels.
  • Evaluation of DNA methylation and histone modifications (acetylation, H3K4 methylation).

Main Results:

  • Chemotherapeutic drugs induce specific epigenetic modifications at the MDR1 locus.
  • MDR1 upregulation is associated with transcriptional activation and potential post-transcriptional regulation.
  • Histone modifications, particularly H3 acetylation and H3K4 methylation, dramatically change within the MDR1 locus.
  • These histone changes correlate directly with MDR1 upregulation and the acquisition of the MDR phenotype.

Conclusions:

  • Chemotherapeutic agents actively induce epigenetic alterations in the MDR1 promoter region.
  • These drug-induced epigenetic changes enhance the multidrug resistance phenotype in cancer cells.
  • Understanding these mechanisms offers potential targets for overcoming chemotherapy resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...